期刊文献+

转移相关因子-3在宫颈癌浸润转移中的相关性研究 被引量:1

Study on the correlation between metastasis-associated factor-3 and invasion and metastasis of cervical cancer
原文传递
导出
摘要 目的研究转移相关因子-3(MTA3)及E-cadherin蛋白在宫颈癌中的表达,并分析两者间的相关性。方法利用免疫组化染色SABC法检测85例人体宫颈癌标本中MTA3和E-cadherin蛋白的表达。结果低分化宫颈鳞状细胞癌和高分化宫颈鳞状细胞癌中MTA3和E-cadherin的阳性表达率分别为21.74%、68.97%和30.43%、62.07%,差异有统计学意义(P<0.05)。宫颈癌临床分期Ⅱa1组和Ⅰa组中MTA3及E-cadherin的阳性表达率分别为27.78%、72.72%和27.78%、60.60%,差异有统计学意义(P<0.05)。有淋巴结转移组和无淋巴结转移组中MTA3及E-cadherin的阳性表达率分别为25.92%、58.62%和33.33%、53.45%,差异有统计学意义(P<0.05)。结论 MTA3表达缺失常伴随E-cadherin表达减少,提示MTA3是宫颈癌晚期和淋巴转移的重要因子。 Objective To explore the expressions of metastasis- associated factor- 3( MTA3) and E- cadherin protein in cervical cancer,analyze the correlation. Methods Immunohistochemical SABC method was used to detect the expressions of MTA3 and E- cadherin in 85 cases with cervical cancer. Results The positive expression rates of MTA3 and E- cadherin in poorly- differentiated cervical squamous cell carcinoma and highly- differentiated cervical squamous cell carcinoma were 21. 74%,68. 97% and 30. 43%,62. 07%,respectively,there were statistically significant differences( P 〈0. 05). The positive expression rates of MTA3 and E- cadherin in Ⅱa1 group and Ⅰa group were 27. 78%,72. 72% and 27. 78%,60. 60%,respectively,there were statistically significant differences( P 〈0. 05). The positive expression rates of MTA3 and E- cadherin in cases with lymph node metastasis and cases without lymph node metastasis were25. 92%,58. 62% and 33. 33%,53. 45%,respectively,there were statistically significant differences( P 〈0. 05). Conclusion MTA3 expression deletion is frequently associated with low expression of E- cadherin,which indicates that MTA3 is an important factor in advanced cervical cancer and lymph node metastasis of cervical cancer.
出处 《中国妇幼保健》 CAS 2015年第27期4704-4706,共3页 Maternal and Child Health Care of China
基金 广东省医学科学技术研究基金〔A2013409〕
关键词 宫颈癌 转移相关因子-3 上皮间质化 转移 Cervical cancer Metastasis-associated factor-3 Epithelial-mesenchymal transition Metastasis
  • 相关文献

参考文献11

  • 1Forouzanfar MH,FOReman KJ,Delossantos AM,et al.Breast and cervical cancer in 187 countries between 1980and 2010:a systematic analysis[J].Lancet,2011,378(9801):1461-1484.
  • 2Ferlay J,Shin HR,Bray F,et al.Estimates of worldwide burden of cancerin 2008,GLOBOCAN 2008[J].Int J Cancer,2010,127(12):2893-2917.
  • 3赵荣志(综述),吴志浩(审校),周清华(审校).上皮细胞间质化与肿瘤的转移[J].中国肺癌杂志,2011,14(7):620-624. 被引量:10
  • 4Wen H,Wu X,Li Z,et al.A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer[J].Int J Gynecol Cancer,2012,22(2):296-302.
  • 5Toh Y,Nicolson GL.The role of the MTA family and their encoded protein in human cancers:molecular function and clinical implications[J].Clin Exp Metastasis,2009,26(3):215-227.
  • 6Fujita N,Jaye DL,Kajita M,et al.MTA3,a Mi-2/NuRD complex subunit,regulates cell,an invasive growth pathway in breast cancer[J].Cell,2003,113(2):207-219.
  • 7Berx G,Cleton-Jansen AM,Nollet F,et al.E-cadherin is a tumour/invasion suppressor gene mutated in human Iobuloe breast cancers[J].EMBO J,1995,14(24):6107-6115.
  • 8Savagner P.The epithelial-mesenchymal transition(EMT)phenomenon[J].Ann Oncol,2010,21(Suppl 7):vii89-vii92.
  • 9Usami Y,Satake S,Nakayama M,et al.Snail-assosicted epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression[J].J Pahtol,2008,215(3):330-339.
  • 10Hardy KM,Booth BW,Hendrix MJ,et al.Erb B/EGF signaling and EMT in mammary development and breast cancer[J].J Mammary Gland Biol Neoplasia,2010,15(2):191-199.

二级参考文献1

共引文献9

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部